Mild reactions may resolve by discontinuing supplements, while severe symptoms may require medical intervention, such as supportive care or medication
Time allotted for each presentation may be limited
In VRK2-WT cells, as expected, most of SLC7A11 was redistributed to the ER after 1 h of BFA treatment, while at 4 h after BFA removal, almost all the cells showed co-localization of SLC7A11 and the Golgi marker Golgin-97
For the estimated 1.5 million Americans living with lupus, and millions more worldwide, conventional treatments often involve a difficult tradeoff: suppress the immune system broadly to reduce attacks on healthy tissue, but leave the body vulnerable to infections and long-term complications
Khavinson VKh, Bondarev IE, Butyugov AA
Curr Opin Psychiatry (2015) 28(1):16